Archimediq ApS: Financial statements 2025
CVR: 45368599
Source: annual report 2025, Danish Business Authority
30/01/2025 – 31/12/2025
Archimediq ApS (CVR 45368599) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -103,824 and a net result of DKK -428,002. Equity in the 2025 report amounted to DKK -471,247.
- Gross Profit
- DKK -103,824
- Profit/Loss
- DKK -428,002
- Equity
- DKK -471,247
- Total Assets
- DKK 1,252,385
- Employees
- 0
Official annual report
How creditworthy is Archimediq ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of May 15, 2025, Kjeld Tage Pharao is registered as director of Archimediq ApS.
As of May 15, 2025, Rune Schmidt Nielsen has stepped down as director of Archimediq ApS.
As of January 30, 2025, Rune Schmidt Nielsen is registered as director of Archimediq ApS.
As of January 30, 2025, Kjeld Tage Pharao Holding ApS is registered as an owner of Archimediq ApS with an ownership share of 25%.
As of January 30, 2025, Xapana ApS is registered as an owner of Archimediq ApS with an ownership share of 20%.
Archimediq ApS was founded on January 30, 2025.
About Archimediq ApS
Archimediq ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2025. The company is registered under the industry Computerprogrammering. The management consists of Kjeld Tage Pharao. The company is owned by Kjeld Tage Pharao Holding ApS, Xapana ApS and Nisaba ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -103,824 and a net result of DKK -428,002. Equity in the 2025 report amounted to DKK -471,247.